Penn Medicine – Cellicon Valley ’21 – The Future of Cell and Gene Therapies

Penn Medicine – Cellicon Valley ’21 – The Future of Cell and Gene Therapies

Thursday, May 6, 2021 – Friday, May 7, 2021


This year’s virtual return to Cellicon Valley promises an in-depth exploration of some of the most exciting areas of cellular therapy research. Hold the date now and plan to join us for any or all of these seven general sessions and more:

  • Real World Experience and the Newest CARs: Survey in disease indication
  • Overcoming Resistance: to monotherapy CAR’s must have clinical data
  • COVID clinical experience panel
  • Gene Delivery and Editing for Better CARs
  • CAR’s on the Unpaved Road
  • Allogeneic CAR-Ts, NKs, iPSC’s
  • Globalization of CAR T Cell Therapies India, Costa Rica, Brazil

Each session will feature multiple speakers and topics. The interactive program will use a state-of-the-art platform, ensuring ample opportunity for discussion and networking. A virtual exhibit hall will feature the latest from industry. You won’t want to miss this event.

Leave a Reply

↑ back to top

The BABCPHL recognizes our Club Level Members:

  • Almac
  • American Airlines
  • Cigna
  • Cigna
  • Duane Morris
  • EisnerAmper LLP
  • Faegre Drinker Biddle & Reath LLP
  • Fisher Phillips
  • HSBC
  • International Products Corporation
  • Johnson, Kendall & Johnson, Inc.
  • KPMG
  • Morgan Lewis
  • Penn Medicine
  • Welsh Government